Lucira Health
Latest round
- Series C
Last raised
- Aug 2020
Total raised
- $48M
Investors
- 13
About Lucira Health
, formerly known as Diassess Inc, develops DNA- and RNA-based diagnostic tools for infectious diseases and provides easily understandable results. The firm offers a home test kit that can detect the SARS-CoV-2 virus. The test kit is fully disposable, easy to use, and can be used in homes. The firm home test is kit is only authorized by FDA under EUA, for authorization of the emergency use of in vitro diagnostics for detection of the SARS-CoV-2 virus.
Who invested in Lucira Health
13 investors across 5 rounds
See all investors in Lucira Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lucira Health
Who invested in Lucira Health?
Lucira Health has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lucira Health raised?
Lucira Health has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Lucira Health last raise money?
Lucira Health's most recent round on record is a Series C, in Aug 2020.
What does Lucira Health do?
, formerly known as Diassess Inc, develops DNA- and RNA-based diagnostic tools for infectious diseases and provides easily understandable results.
Where is Lucira Health headquartered?
Lucira Health is headquartered in Emeryville, US.
Which VCs invest in companies like Lucira Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Lucira Health's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Lucira Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.